Insights

Expanding Pharmaceutical Portfolio Olpha Global has a diverse portfolio with over 60 finished dosage forms and actively develops generics, including a recent launch of a cardiology medication. This indicates opportunities for suppliers of pharmaceutical ingredients, raw materials, and formulation technologies tailored to generic drug manufacturing.

Investment in Manufacturing Capacity The company's recent EUR 4.4 million investment in manufacturing equipment underscores a commitment to increasing production capacity and technological advancement, opening potential sales avenues for advanced machinery, automation solutions, and process optimization technologies.

Quality Certifications and Compliance Olpha’s compliance with EU GMP, U.S. cGMP, TGA, and other international standards highlights a focus on quality and regulatory expertise, suggesting opportunities for suppliers of quality control systems, certification consultancy, and regulatory compliance solutions.

Strategic Leadership and Growth Strong leadership under Chairman Juris Bundulis since 2021 facilitates strategic alignment and expansion efforts, making the company likely receptive to partnerships in R&D, licensing, and strategic collaborations in both European and global markets.

Market Position and Regional Focus As one of the largest pharmaceutical manufacturers in the Baltic region with recent launches bolstering its European presence, Olpha offers prospects for regional suppliers of production materials, logistics support, and distribution services aimed at expanding their footprint in Northern and Eastern Europe.

Olpha Tech Stack

Olpha uses 8 technology products and services including ISO, oEmbed, Swiper, and more. Explore Olpha's tech stack below.

  • ISO
    Certificates
  • oEmbed
    Dev Tools
  • Swiper
    Javascript Libraries
  • Microsoft Office
    Office Suites
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • X-Content-Type-Options
    Web & Portal Technology
  • Facebook
    Widgets

Olpha's Email Address Formats

Olpha uses at least 2 format(s):
Olpha Email FormatsExamplePercentage
FLast@olainfarm.lvJDoe@olainfarm.lv
57%
First.Last@olainfarm.lvJohn.Doe@olainfarm.lv
38%
First@olainfarm.lvJohn@olainfarm.lv
4%
FirstLast@olainfarm.lvJohnDoe@olainfarm.lv
1%
First.Last@olpha.euJohn.Doe@olpha.eu
100%

Frequently Asked Questions

Where is Olpha's headquarters located?

Minus sign iconPlus sign icon
Olpha's main headquarters is located at 5 Rūpnīcu Street Olaine, Olaines Nov. lv-2114 Latvia. The company has employees across 4 continents, including EuropeAsiaNorth America.

What is Olpha's phone number?

Minus sign iconPlus sign icon
You can contact Olpha's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Olpha's official website and social media links?

Minus sign iconPlus sign icon
Olpha's official website is olpha.eu and has social profiles on LinkedIn.

What is Olpha's NAICS code?

Minus sign iconPlus sign icon
Olpha's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Olpha have currently?

Minus sign iconPlus sign icon
As of May 2026, Olpha has approximately 360 employees across 4 continents, including EuropeAsiaNorth America. Key team members include Cfo: I. L.Cfo: M. T.Cio: M. R.. Explore Olpha's employee directory with LeadIQ.

What industry does Olpha belong to?

Minus sign iconPlus sign icon
Olpha operates in the Pharmaceutical Manufacturing industry.

What technology does Olpha use?

Minus sign iconPlus sign icon
Olpha's tech stack includes ISOoEmbedSwiperMicrosoft OfficePHPYoast SEOX-Content-Type-OptionsFacebook.

What is Olpha's email format?

Minus sign iconPlus sign icon
Olpha's email format typically follows the pattern of FLast@olainfarm.lv. Find more Olpha email formats with LeadIQ.

When was Olpha founded?

Minus sign iconPlus sign icon
Olpha was founded in 1972.

Olpha

Pharmaceutical ManufacturingOlaines Nov., Latvia201-500 Employees

Olpha, the subsidiary of JSC AB City, is one of the largest companies in the Baltic states with more than 50 years of experience
in the production of medicines and chemical
pharmaceutical products. Portfolio contains over 60 FDFs, 25 APIs and more than 25 Intermediates. The key areas of specialization in FDFs include neurology, cardiology, infectology and allergology. Olainfarm has a long-standing technological and know-how advantage in adamantane, quinuclidine and nitrofurane chemistry.

Olpha Group includes a network of medical and pharmaceutical enterprises specialising in their own discipline, covering a wide range of areas - supplement manufacturers Silvanols, RFF and Jonax.
Olainfarm is certified in accordance with the requirements of the EU GMP for APIs and FDFs, the U.S. cGMP for certain APIs (FDA), TGA for FDFs (Australia), CEP for certain APIs, ISO 14001 Environmental Management System and ISO 17025 Laboratory Management System.

Visit http://www.olpha.eu/ for more information. 
 
Current vacancies: https://olpha.eu/en/careers

Section iconCompany Overview

Headquarters
5 Rūpnīcu Street Olaine, Olaines Nov. lv-2114 Latvia
Phone number
Website
olpha.eu
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1972
Employees
201-500

Section iconFunding & Financials

  • $500M$1B

    Olpha's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $500M$1B

    Olpha's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.